Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis

Arthritis Research and Therapy

Volumn 13, Issue 5, 2011, Pages

  Lee, Sung Ji ^a   Nam, Kwang Il ^a   Jin, Hye Mi ^a   Cho, Young Nan ^a   Lee, Song Eun ^a   Kim, Tae Jong ^a   Lee, Shin Seok ^a   Kee, Seung Jung ^a   Lee, Keun Bae ^a   Kim, Nacksung ^a   Park, Yong Wook ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR; URATE; TNFSF11 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BONE DESTRUCTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GOUT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MAST CELL; MONONUCLEAR CELL; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; T CELL DEPLETION; T LYMPHOCYTE; ADULT; AGED; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ARTHRITIS, GOUTY; BONE RESORPTION; CELL MOVEMENT; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCLASTS; RANK LIGAND; T-LYMPHOCYTES;

EID: 80053930859     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3483     Document Type: Article

References (48)

1. Richette P, Bardin T: Gout. Lancet 375:318-328
2. Rider TG, Jordan KM: The modern management of gout. Rheumatology (Oxford) 49:5-14
3. Nakayama DA, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL: Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum 1984, 27:468-471
4. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM: Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007, 46:1804-1807
5. Palmer DG, Highton J, Hessian PA: Development of the gout tophus. An hypothesis. Am J Clin Pathol 1989, 91:190-195
6. Schumacher HR: Pathology of the synovial membrane in gout. Light and electron microscopic studies. Interpretation of crystals in electron micrographs. Arthritis Rheum 1975, 18:771-782
7. Palmer DG, Hogg N, Denholm I, Allen CA, Highton J, Hessian PA: Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules. Rheumatol Int 1987, 7:187-193
8. Schweyer S, Hemmerlein B, Radzun HJ, Fayyazi A: Continuous recruitment, co-expression of tumour necrosis factor-alpha and matrix metalloproteinases, and apoptosis of macrophages in gout tophi. Virchows Arch 2000, 437:534-539
9. Dalbeth N, Smith T, Nicolson B, Clark B, Callon K, Naot D, Haskard DO, McQueen FM, Reid IR, Cornish J: Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum 2008, 58:1854-1865
10. Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J: Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 62:1549-1556
11. Massey HM, Flanagan AM: Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 1999, 106:167-170
12. Teitelbaum SL: Bone resorption by osteoclasts. Science 2000, 289:1504-1508
13. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176
14. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T: Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999, 163:434-442
15. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM: Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006, 440:692-696
16. Theill LE, Boyle WJ, Penninger JM: RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002, 20:795-823
17. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H: Protein expression and functional difference of membranebound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000, 275:768-775
18. Nakashima T, Takayanagi H: Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 2009, 29:555-567
19. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR: Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998, 152:943-951
20. Rehman Q, Lane NE: Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res 2001, 3:221-227
21. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR: Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000, 43:250-258
22. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM: Mechanisms of TNF-alpha-and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821-831
23. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S: Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43:259-269
24. Schlesinger N, Thiele RG: The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907-1912
25. Choi HK, Mount DB, Reginato AM: Pathogenesis of gout. Ann Intern Med 2005, 143:499-516
26. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL: MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 2006, 116:2262-2271
27. Shi Y, Mucsi AD, Ng G: Monosodium urate crystals in inflammation and immunity. Immunol Rev 233:203-217
28. Kara FM, Doty SB, Boskey A, Goldring S, Zaidi M, Fredholm BB, Cronstein BN: Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum 62:534-541
29. Murakami Y, Akahoshi T, Hayashi I, Endo H, Kawai S, Inoue M, Kondo H, Kitasato H: Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum 2006, 54:455-462
30. Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, Quarta L, Cirulli N, Mancini L, Corrado A, Grassi FR, Grano M: Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 2007, 212:47-55
31. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N: MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 2007, 109:3253-3259
32. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, Shin MH, Park JJ, Kim TJ, Lee SS, Yoo DH, Kang HS: Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1753-1763
33. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304-309
34. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001, 44:1003-1012
35. Konttinen YT, Bergroth V, Nordstrom D, Koota K, Skrifvars B, Hagman G, Friman C, Hamalainen M, Slatis P: Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis 1985, 44:549-555
36. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP: Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) 1999, 38:1074-1080
37. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM: Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001, 167:1072-1080
38. Park YW, Kang YM, Butterfield J, Detmar M, Goronzy JJ, Weyand CM: Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol 2004, 165:2087-2098
39. Ejiri S: The preosteoclast and its cytodifferentiation into the osteoclast: ultrastructural and histochemical studies of rat fetal parietal bone. Arch Histol Jpn 1983, 46:533-557
40. Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304
41. di Giovine FS, Malawista SE, Nuki G, Duff GW: Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 1987, 138:3213-3218
42. di Giovine FS, Malawista SE, Thornton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991, 87:1375-1381
43. Guerne PA, Terkeltaub R, Zuraw B, Lotz M: Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 1989, 32:1443-1452
44. Webb R, Jeffries M, Sawalha AH: Uric acid directly promotes human T-cell activation. Am J Med Sci 2009, 337:23-27
45. Alwan WH, Dieppe PA, Elson CJ, Bradfield JW: Hydroxyapatite and urate crystal induced cytokine release by macrophages. Ann Rheum Dis 1989, 48:476-482
46. O'Gradaigh D, Bord S, Ireland D, Compston JE: Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response. Rheumatology (Oxford) 2003, 42:1429-1430
47. Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q: Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 116:210-217
48. Martinon F, Glimcher LH: Gout: new insights into an old disease. J Clin Invest 2006, 116:2073-2075